Efficacy of Strategies to Reduce Mother-to-Child HIV-1 Transmission in Argentina, 1993–2000
- 1 November 2002
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 31 (3) , 348-353
- https://doi.org/10.1097/00126334-200211010-00012
Abstract
This study evaluated the success of a national program for the prevention of mother-to-child transmission (MTCT) of HIV-1 in 874 mother-infant pairs from Buenos Aires and surroundings. This population was referred to the National Reference Center for AIDS for diagnosis of neonatal infection during 1993-2000. The data revealed an increase in the use of antiretroviral therapy during pregnancy from 3.2% in 1993-1994 to 73.1% in 1999-2000 and in the use of cesarean delivery (reaching 54.8% in 1999-2000). However, the proportion of HIV-infected women who continued to breast-feed their children remained steady (around 12%). General improvement of the conditions for decreasing MTCT resulted in a significant decrease in the proportion of infected infants from 37.3% before 1995 to 10.7% in 1999-2000 and even 6.5% during 2001. Data on the time of diagnosis indicated that only 42.7% of the women knew about their HIV status before pregnancy, 44.8 knew during pregnancy, and 12.3% knew after the birth of their child. The main risk factor for HIV infection in the mothers was heterosexual contact (73%), and in the fathers, it was injection drug use (67%). These results point out the urgent need to develop additional strategies for prevention of MTCT of HIV-1 to generalize education, counseling, and testing of young women.Keywords
This publication has 18 references indexed in Scilit:
- Advances and research directions in the prevention of mother-to-child HIV-1 transmissionThe Lancet, 2000
- Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxisObstetrics & Gynecology, 1999
- Mode of Delivery and the Risk of Vertical Transmission of HIV-1New England Journal of Medicine, 1999
- The Mode of Delivery and the Risk of Vertical Transmission of Human Immunodeficiency Virus Type 1 — A Meta-Analysis of 15 Prospective Cohort StudiesNew England Journal of Medicine, 1999
- Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trialThe Lancet, 1999
- Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency VirusNew England Journal of Medicine, 1998
- After AIDS Clinical Trial 076: The Changing Pattern of Zidovudine Use during Pregnancy, and the Subsequent Reduction in the Vertical Transmission of Human Immunodeficiency Virus in a Cohort of Infected Women and Their InfantsThe Journal of Infectious Diseases, 1996
- Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to InfantNew England Journal of Medicine, 1996
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- POSTNATAL TRANSMISSION OF AIDS-ASSOCIATED RETROVIRUS FROM MOTHER TO INFANTThe Lancet, 1985